Stryker Rejuvenate and ABG-II Important Dates and Answers

For patients who are seeking information, here are the relevant dates for the Stryker Rejuvenate System as sold in the United States: Stryker Rejuvenate Hip Implants Since the 1980s, medical and scientific literature has reported corrosion to be a problem when Ti and CoCr have been used

  • On June 3, 2008, Stryker received FDA clearance to sell its Rejuvenate and ABG II System (“Rejuvenate System”) in the United States.
  • In February 2009, Stryker released its Rejuvenate Hip Systems, the latest evolution in Stryker OmniFit and Secure-Fit Hip systems.
  • On October 20, 2009, the FDA approves the use of a ‘Modular Neck Stem’ for use in Stryker’s Rejuvenate System.
  • Stryker marketed the Rejuvenate System to surgeons on the representation that it would enable them to better personalize the implant to each patient's unique anatomy.
  • The Rejuvenate System is comprised of separate femoral stem and neck components and offers a variety of sizing options intraoperatively.
  • The Rejuvenate System combines the material characteristics of TMZF (Ti-12Mo-6Zr-2Fe) with a plasma sprayed coating of commercially-pure Ti and PureFix HA for the stem and CoCr for the neck. Stryker claims that laboratory testing demonstrates the compatibility of these materials without concern for fretting and corrosion.
  • Despite Stryker’s claims, this combination of materials has been reported to cause fretting, galvanization, and corrosion. Since the 1980s, medical and scientific literature has reported corrosion to be a problem when Ti and CoCr have been used at modular junctions in medical implants. In its marketing and sale of the device, Stryker represented and warranted that its proprietary materials alleviate this problem.
  • Stryker holds two patents for modular implant devices. Currently, Stryker has a pending application to patent a modular hip prosthesis similar to the Rejuvenate System.
  • In April of 2012, Stryker issued an Urgent Field Safety Notice to surgeons and hospitals regarding the Rejuvenate System.
  • In this notice, Stryker acknowledged that it had received reports of device failure due to heavy metal contamination. The Urgent Field Safety Notice specifically referred to failures at the taper neck junction between the neck and stem due to corrosion and fretting.
  • The notice specifically warned of the Stryker Rejuvenate System causing metallosis, necrosis, osteolysis and other tissue destruction.
  • On July 6, 2012 Stryker initiated a worldwide recall of its Rejuvenate and ABG II hip replacement systems.

The DiCello Law Firm Is One Of The Leading Law Firm Holding Stryker Accountable

The DiCello Law Firm was one of the first law firms in the United States to pursue claims on behalf of patients who received the Stryker Rejuvenate System. As a result The DiCello Firm continues to be among the most advanced firms in the Country in dealing with the unique challenges this failed device poses for patients. There have been nearly 30,000 of these defective and dangerous hips sold throughout the world with the vast majority of recipients being United States’ citizens. The DiCello Law Firm will get justice for Victims of this device.


Please contact us for any additional information. We will be in contact as soon as possible. Thank you.
By submitting this form, you accept our privacy policy.

Do You Want To Learn More About The Stryker Rejuvenate and ABG-II Modular Hip Implant Recall?

Below is a list of articles and blogs that lawyers from The DiCello Law Firm have written about the recall of Rejuvenate and ABG-II modular implants. If you would prefer to just speak with one of our attorneys, please call us toll free at 1-888-778-8880 or fill out the form.